Item 5.07. Submission of Matters to a Vote of Security Holders.

Fusion Pharmaceuticals Inc. (the "Company") held its annual meeting of shareholders on June 14, 2022 (the "Annual Meeting"). At the Annual Meeting, the Company's shareholders voted in the following manner with respect to the following proposals:



    1.   The election of Directors, each to serve until the 2023 annual meeting of
         shareholders. The final voting results were as follows:



Nominee                             For           Against        Abstain
Donald Bergstrom, M.D., Ph.D.     26,898,848             0           8,390
Pablo Cagnoni, M.D.               26,890,723             0          16,515
Johan Christenson, Ph.D.          26,898,798             0           8,440
Barbara Duncan                    23,778,571             0       3,128,667
Steve Gannon                      26,898,783             0           8,455
Chau Khuong                       26,870,584             0          36,654
Philina Lee, Ph.D.                26,898,982             0           8,256
Heather Preston, M.D.             23,766,724             0       3,140,514
John Valliant, Ph.D.              26,898,848             0           8,390



    2.   The ratification of the appointment of PricewaterhouseCoopers LLP as the
         Company's independent registered public accounting firm the current
         fiscal year ending December 31, 2022 was approved as follows:



For:         27,628,417
Against:              0
Abstain:          7,232

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses